Mona Kotecha, M.D.

Mona is the Chief Medical Officer of Ventus Therapeutics. Mona was most recently Chief Medical Officer of ExploR&D, a division of Eli Lilly’s Catalyze360, which serves the biotechnology ecosystem. Mona brings 20 years of patient care and pharmaceutical industry experience to Ventus. Prior to her role at Eli Lilly, Mona led clinical development for pain and psychiatry at Biogen, where she was the clinical lead for the development of zuranolone in depressive disorders. She previously held roles of increasing responsibility at Gilead Sciences, where she was instrumental in the development of Jyseleca in immunology and inflammation. Mona is a board-certified anesthesiologist and acute pain expert. She trained as a physician at the University of California-San Francisco and Dartmouth-Hitchcock Medical Center, and received her M.D. from the Yale University School of Medicine and B.A. from Dartmouth College.